Table 2. .
Trial |
r |
P |
No fluid | −0.968 | .007 |
Ad libitum | −0.886 | .046 |
Oral | −0.955 | .011 |
Intravenous | −0.974 | .005 |
Oral + intravenous | −0.945 | .015 |
Overall | −0.870 | <.001 |
Trial |
r |
P |
No fluid | −0.968 | .007 |
Ad libitum | −0.886 | .046 |
Oral | −0.955 | .011 |
Intravenous | −0.974 | .005 |
Oral + intravenous | −0.945 | .015 |
Overall | −0.870 | <.001 |